Ascendis Pharma A/S Increase Decrease Through Share-based Payment Transactions
Ascendis Pharma A/S (ASND) reported Increase Decrease Through Share-based Payment Transactions of EUR 116.17 million for the 12-month period ending 2025-12-31, per its 20-F filed 2026-02-11.
Financial Statements › Notes › Compensation Related Costs
ifrs-full:IncreaseDecreaseThroughSharebasedPaymentTransactions · last filed 2026-02-11
- Ascendis Pharma A/S increase decrease through share-based payment transactions for the quarter ending 2025-12-31 was 29.95M EUR, a 14.24% increase year-over-year.
- Ascendis Pharma A/S increase decrease through share-based payment transactions for the quarter ending 2025-09-30 was 30.64M EUR, a 17.99% increase year-over-year.
- Ascendis Pharma A/S increase decrease through share-based payment transactions for the quarter ending 2025-06-30 was 30.02M EUR, a 15.27% increase year-over-year.
- Ascendis Pharma A/S increase decrease through share-based payment transactions for the quarter ending 2025-03-31 was 25.56M EUR, a 47.90% increase year-over-year.
| Period end | Increase Decrease Through Share-based Payment Transactions 3 month | Increase Decrease Through Share-based Payment Transactions 6 month | Increase Decrease Through Share-based Payment Transactions 9 month | Increase Decrease Through Share-based Payment Transactions 12 month |
|---|---|---|---|---|
| 2025-12-31 | 29.95M EUR derived: 20-F 12 month − 6-K 9 month · filed 2026-02-11 | 60.59M EUR derived: sum of 2 quarters · filed 2026-02-11 | 90.61M EUR derived: sum of 3 quarters · filed 2026-02-11 | 116.17M EUR 20-F · filed 2026-02-11 |
| 2025-09-30 | 30.64M EUR derived: 6-K 9 month − 6-K 6 month · filed 2025-11-12 | 60.66M EUR derived: sum of 2 quarters · filed 2025-11-12 | 86.22M EUR 6-K · filed 2025-11-12 | 112.44M EUR derived: sum of 4 quarters · filed 2026-02-11 |
| 2025-06-30 | 30.02M EUR derived: 6-K 6 month − 6-K 3 month · filed 2025-08-07 | 55.58M EUR 6-K · filed 2025-08-07 | 81.80M EUR derived: sum of 3 quarters · filed 2026-02-11 | 107.77M EUR derived: sum of 4 quarters · filed 2026-02-11 |
| 2025-03-31 | 25.56M EUR 6-K · filed 2025-05-01 | 51.78M EUR derived: sum of 2 quarters · filed 2026-02-11 | 77.74M EUR derived: sum of 3 quarters · filed 2026-02-11 | 103.79M EUR derived: sum of 4 quarters · filed 2026-02-11 |
| 2024-12-31 | 26.22M EUR derived: 20-F 12 month − 6-K 9 month · filed 2026-02-11 | 52.19M EUR derived: sum of 2 quarters · filed 2026-02-11 | 78.23M EUR derived: sum of 3 quarters · filed 2026-02-11 | 95.51M EUR 20-F · filed 2026-02-11 |
| 2024-09-30 | 25.96M EUR derived: 6-K 9 month − 6-K 6 month · filed 2025-11-12 | 52.01M EUR derived: sum of 2 quarters · filed 2025-11-12 | 69.29M EUR 6-K · filed 2025-11-12 | 85.20M EUR derived: sum of 4 quarters · filed 2026-02-11 |
| 2024-06-30 | 26.05M EUR derived: 6-K 6 month − 6-K 3 month · filed 2025-08-07 | 43.33M EUR 6-K · filed 2025-08-07 | 59.23M EUR derived: sum of 3 quarters · filed 2026-02-11 | 76.42M EUR derived: sum of 4 quarters · filed 2026-02-11 |
| 2024-03-31 | 17.28M EUR 6-K · filed 2025-05-01 | 33.19M EUR derived: sum of 2 quarters · filed 2026-02-11 | 50.37M EUR derived: sum of 3 quarters · filed 2026-02-11 | 70.25M EUR derived: sum of 4 quarters · filed 2026-02-11 |
| 2023-12-31 | 15.91M EUR derived: 20-F 12 month − 6-K 9 month · filed 2026-02-11 | 33.09M EUR derived: sum of 2 quarters · filed 2026-02-11 | 52.97M EUR derived: sum of 3 quarters · filed 2026-02-11 | 66.66M EUR 20-F · filed 2026-02-11 |
| 2023-09-30 | 17.18M EUR derived: 6-K 9 month − 6-K 6 month · filed 2024-11-14 | 37.06M EUR derived: sum of 2 quarters · filed 2024-11-14 | 50.75M EUR 6-K · filed 2024-11-14 | 64.63M EUR derived: sum of 4 quarters · filed 2025-02-12 |
| 2023-06-30 | 19.88M EUR derived: 6-K 6 month − 6-K 3 month · filed 2024-09-03 | 33.57M EUR 6-K · filed 2024-09-03 | 47.44M EUR derived: sum of 3 quarters · filed 2025-02-12 | 60.98M EUR derived: sum of 4 quarters · filed 2025-02-12 |
| 2023-03-31 | 13.69M EUR 6-K · filed 2024-05-02 | 27.56M EUR derived: sum of 2 quarters · filed 2025-02-12 | 41.10M EUR derived: sum of 3 quarters · filed 2025-02-12 | 57.90M EUR derived: sum of 4 quarters · filed 2025-02-12 |
| 2022-12-31 | 13.87M EUR derived: 20-F 12 month − 6-K 9 month · filed 2025-02-12 | 27.41M EUR derived: sum of 2 quarters · filed 2025-02-12 | 44.21M EUR derived: sum of 3 quarters · filed 2025-02-12 | 64.18M EUR 20-F · filed 2025-02-12 |
| 2022-09-30 | 13.54M EUR derived: 6-K 9 month − 6-K 6 month · filed 2023-11-07 | 30.34M EUR derived: sum of 2 quarters · filed 2023-11-07 | 50.31M EUR 6-K · filed 2023-11-07 | 64.45M EUR derived: sum of 4 quarters · filed 2024-02-07 |
| 2022-06-30 | 16.80M EUR derived: 6-K 6 month − 6-K 3 month · filed 2023-09-05 | 36.77M EUR 6-K · filed 2023-09-05 | 50.92M EUR derived: sum of 3 quarters · filed 2024-02-07 | 64.20M EUR derived: sum of 4 quarters · filed 2024-02-07 |
| 2022-03-31 | 19.97M EUR 6-K · filed 2023-04-27 | 34.11M EUR derived: sum of 2 quarters · filed 2024-02-07 | 47.40M EUR derived: sum of 3 quarters · filed 2024-02-07 | 63.72M EUR derived: sum of 4 quarters · filed 2024-02-07 |
| 2021-12-31 | 14.15M EUR derived: 20-F 12 month − 6-K 9 month · filed 2024-02-07 | 27.43M EUR derived: sum of 2 quarters · filed 2024-02-07 | 43.75M EUR derived: sum of 3 quarters · filed 2024-02-07 | 66.83M EUR 20-F · filed 2024-02-07 |
| 2021-09-30 | 13.29M EUR derived: 6-K 9 month − 6-K 6 month · filed 2022-11-02 | 29.61M EUR derived: sum of 2 quarters · filed 2022-11-02 | 52.68M EUR 6-K · filed 2022-11-02 | 67.07M EUR derived: sum of 4 quarters · filed 2023-02-16 |
| 2021-06-30 | 16.32M EUR derived: 6-K 6 month − 6-K 3 month · filed 2022-08-10 | 39.40M EUR 6-K · filed 2022-08-10 | 53.78M EUR derived: sum of 3 quarters · filed 2023-02-16 | 64.20M EUR derived: sum of 4 quarters · filed 2023-02-16 |
| 2021-03-31 | 23.08M EUR 6-K · filed 2022-05-11 | 37.47M EUR derived: sum of 2 quarters · filed 2023-02-16 | 47.88M EUR derived: sum of 3 quarters · filed 2023-02-16 | 61.30M EUR derived: sum of 4 quarters · filed 2023-02-16 |
| 2020-12-31 | 14.39M EUR derived: 20-F 12 month − 6-K 9 month · filed 2023-02-16 | 24.81M EUR derived: sum of 2 quarters · filed 2023-02-16 | 38.22M EUR derived: sum of 3 quarters · filed 2023-02-16 | 53.17M EUR 20-F · filed 2023-02-16 |
| 2020-09-30 | 10.42M EUR derived: 6-K 9 month − 6-K 6 month · filed 2021-11-10 | 23.83M EUR derived: sum of 2 quarters · filed 2021-11-10 | 38.78M EUR 6-K · filed 2021-11-10 | 50.06M EUR derived: sum of 4 quarters · filed 2022-03-02 |
| 2020-06-30 | 13.41M EUR derived: 6-K 6 month − 6-K 3 month · filed 2021-08-27 | 28.36M EUR 6-K · filed 2021-08-27 | 39.65M EUR derived: sum of 3 quarters · filed 2022-03-02 | 47.72M EUR derived: sum of 4 quarters · filed 2022-03-02 |
| 2020-03-31 | 14.95M EUR 6-K · filed 2021-05-27 | 26.23M EUR derived: sum of 2 quarters · filed 2022-03-02 | 34.30M EUR derived: sum of 3 quarters · filed 2022-03-02 | 43.00M EUR derived: sum of 4 quarters · filed 2022-03-02 |
| 2019-12-31 | 11.28M EUR derived: 20-F 12 month − 6-K 9 month · filed 2022-03-02 | 19.36M EUR derived: sum of 2 quarters · filed 2022-03-02 | 28.05M EUR derived: sum of 3 quarters · filed 2022-03-02 | 37.49M EUR 20-F · filed 2022-03-02 |
| 2019-09-30 | 8.07M EUR derived: 6-K 9 month − 6-K 6 month · filed 2020-11-12 | 16.77M EUR derived: sum of 2 quarters · filed 2020-11-12 | 26.20M EUR 6-K · filed 2020-11-12 | 33.07M EUR derived: sum of 4 quarters · filed 2021-03-10 |
| 2019-06-30 | 8.70M EUR derived: 6-K 6 month − 6-K 3 month · filed 2020-08-27 | 18.13M EUR 6-K · filed 2020-08-27 | 25.00M EUR derived: sum of 3 quarters · filed 2021-03-10 | 28.88M EUR derived: sum of 4 quarters · filed 2021-03-10 |
| 2019-03-31 | 9.44M EUR 6-K · filed 2020-05-19 | 16.30M EUR derived: sum of 2 quarters · filed 2021-03-10 | 20.19M EUR derived: sum of 3 quarters · filed 2021-03-10 | 24.41M EUR derived: sum of 4 quarters · filed 2021-03-10 |
| 2018-12-31 | 6.87M EUR derived: 20-F 12 month − 6-K 9 month · filed 2021-03-10 | 10.75M EUR derived: sum of 2 quarters · filed 2021-03-10 | 14.97M EUR derived: sum of 3 quarters · filed 2021-03-10 | 19.65M EUR 20-F · filed 2021-03-10 |
| 2018-09-30 | 3.89M EUR derived: 6-K 9 month − 6-K 6 month · filed 2019-11-18 | 8.11M EUR derived: sum of 2 quarters · filed 2019-11-18 | 12.79M EUR 6-K · filed 2019-11-18 | 15.57M EUR derived: sum of 4 quarters · filed 2020-04-03 |
| 2018-06-30 | 4.22M EUR derived: 6-K 6 month − 6-K 3 month · filed 2019-08-28 | 8.90M EUR 6-K · filed 2019-08-28 | 11.69M EUR derived: sum of 3 quarters · filed 2020-04-03 | 13.60M EUR derived: sum of 4 quarters · filed 2020-04-03 |
| 2018-03-31 | 4.68M EUR 6-K · filed 2019-05-30 | 7.46M EUR derived: sum of 2 quarters · filed 2020-04-03 | 9.38M EUR derived: sum of 3 quarters · filed 2020-04-03 | 11.68M EUR derived: sum of 4 quarters · filed 2020-04-03 |
| 2017-12-31 | 2.79M EUR derived: 20-F 12 month − 6-K 9 month · filed 2020-04-03 | 4.70M EUR derived: sum of 2 quarters · filed 2020-04-03 | 7.00M EUR derived: sum of 3 quarters · filed 2020-04-03 | 9.71M EUR 20-F · filed 2020-04-03 |
| 2017-09-30 | 1.91M EUR derived: 6-K 9 month − 6-K 6 month · filed 2018-11-28 | 4.22M EUR derived: sum of 2 quarters · filed 2018-11-28 | 6.92M EUR 6-K · filed 2018-11-28 | |
| 2017-06-30 | 2.31M EUR derived: 6-K 6 month − 6-K 3 month · filed 2018-08-29 | 5.01M EUR 6-K · filed 2018-08-29 | ||
| 2017-03-31 | 2.71M EUR 6-K · filed 2018-05-30 | |||
| 2016-12-31 | 7.32M EUR 20-F · filed 2019-04-03 | |||
| 2015-12-31 | 1.71M EUR 20-F · filed 2018-03-28 |